Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Get Adobe Flash player

Acquisition

Video: Valeant buys rights to Visudyne Add to ...

Valeant Pharmaceuticals has purchased the rights to Visudyne, an eye drug, from Vancouver-based QLT Inc.

 

Drive

Technology